This inventor holds 8 USPTO granted patents and 9 published patent applications. Top assignee: Abbvie Inc.. Active years: 2018-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2023
Title: Juki Wing-Keung Ng: Innovator in Women's Health
Introduction
Juki Wing-Keung Ng is a notable inventor based in Highland Park, IL (US). He has made significant contributions to the field of women's health, particularly in the treatment of heavy menstrual bleeding. With a total of 8 patents to his name, Ng's work is recognized for its innovative approaches and practical applications.
Latest Patents
One of Ng's latest patents focuses on methods of treating heavy menstrual bleeding. This invention relates to administering an effective amount of 4-((R)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric acid or a pharmaceutically acceptable salt thereof, in combination with estrogens and progestogens. This method is designed for subjects with or without uterine fibroids who are in need of treatment.
Career Highlights
Juki Wing-Keung Ng is currently associated with AbbVie Inc., a leading global biopharmaceutical company. His work at AbbVie has allowed him to focus on developing innovative solutions for women's health issues. Ng's dedication to research and development has positioned him as a key figure in his field.
Collaborations
Ng has collaborated with several professionals in his field, including Kristof Chwalisz and Laura A. Williams. These collaborations have enhanced the quality and impact of his research, leading to advancements in treatment options for patients.
Conclusion
Juki Wing-Keung Ng is a prominent inventor whose work in women's health has led to significant advancements in the treatment of heavy menstrual bleeding. His innovative patents and collaborations reflect his commitment to improving patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
